Medications

COVID-19: Physician co-authors analysis of antiviral drug

In a small group of patients hospitalized with severe complications of COVID-19 and treated with the experimental antiviral drug remdesivir, clinical improvement was observed in 68% of patients treated, according to an analysis ...

Diabetes

Bariatric surgery in teens may cut diabetic kidney disease risk

(HealthDay)—Among obese adolescents with type 2 diabetes, metabolic bariatric surgery is associated with decreased rates of hyperfiltration and elevated urinary albumin excretion (UAE), according to a study published in ...

Medications

Linagliptin noninferior for CV risk in early type 2 diabetes

(HealthDay)—Linagliptin is noninferior to glimepiride for adults with relatively early type 2 diabetes and elevated cardiovascular risk, according to a study published online Sept. 19 in the Journal of the American Medical ...

Oncology & Cancer

Drug combo slows progression in advanced breast cancer

(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients with PIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative ...

Psychology & Psychiatry

Mental health treatment, diagnoses up in military children

(HealthDay)—Diagnosed mental health conditions, pharmaceutical treatment, and outpatient visits for mental health all increased among U.S. pediatric military dependents from 2003 to 2015, according to a study published ...

Medications

House Dems announce sweeping investigation of drug pricing

House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political ...

page 6 from 11